Importance Successful minimally invasive parathyroidectomy requires confident and accurate preoperative localization. Several noninvasive imaging techniques are well established for preoperative localization, and others are emerging. Observations Ultrasonography and sestamibi imaging are established preoperative localization techniques with good sensitivity and positive predictive value. Multiphase 4-dimensional computed tomography is a newer technique with arguably superior performance, particularly in the setting of negative or discordant ultrasonography and sestamibi imaging, residual or recurrent primary hyperparathyroidism following a previous surgical operation, and multiglandular disease. Emerging techniques that may further facilitate confident and accurate preoperative localization include ultrasonography, elastography, positron emission tomography, and 4-D magnetic resonance imaging. Conclusions and Relevance The optimal imaging localization algorithm for hyperparathyroidism remains undetermined, but a combination of techniques tailored to the specific scenario will likely yield the best outcomes. An algorithm is proposed that considers test performance, surgeon confidence, patient-specific factors, cost, local radiologic expertise, and patient radiation exposure.
By understanding the relevant anatomy, embryology, and operative considerations and by accurately reporting and addressing the key information the surgeon desires from parathyroid four-dimensional ... Parathyroid four-dimensional (4D) CT is an increasingly used and powerful tool for preoperative localization of abnormal parathyroid tissue in the setting of primary hyperparathyroidism. Accurate a...
1 October 2016 in American Journal of Roentgenology
OBJECTIVE. The purpose of this article is to review the added value of dual-energy CT for characterization of incidental lesions discovered during routine abdominal CT. CONCLUSION. Dual-energy CT allows acquisition of virtual unenhanced images, iodine maps, and virtual monochromatic images, all of which can aid in characterizing incidental lesions at the time of detection. Virtual unenhanced images and iodine maps are used for assessment of enhancement of incidental lesions, which can help differentiate suspicious enhancing lesions from benign nonenhancing lesions. Virtual monochromatic images can be obtained at low energy to improve conspicuity and detection of subtle lesions. Routine use of dual-energy CT may eliminate the need for additional imaging in the workup of some of these incidental lesions.
Intraprocedural depiction of both the ablated liver tumor and entire ablation margin is feasible by using nitrogen 13 ammonia perfusion PET during FDG PET/CT-guided microwave ablation. Purpose To prospectively determine whether nitrogen 13 (13N) ammonia perfusion positron emission tomography (PET) during fluorine 18 fluorodeoxyglucose (FDG) PET/computed tomography (CT)–guided liver tumor ablation can be used to intraprocedurally assess ablation margins. Materials and Methods Eight patients (five women and three men; age range, 36–74 years; mean age, 57 years) were enrolled in this pilot study and underwent FDG PET/CT–guided microwave ablation of 11 FDG-avid liver metastases (mean diameter, 22 mm; range, 11–34 mm). All procedures were performed between March 2014 and December 2016. Complete ablation margin visibility and minimum ablation margin thickness were assessed by using intraprocedural 13N-ammonia perfusion PET compared with 24-hour postprocedural MR imaging by two independent blinded radiologists. Local tumor progression for each ablated tumor was assessed at follow-up imaging for 3–38 months (median, 17.6 months). Descriptive analysis was performed. Results Eleven of 11 (100%) a...
To assess reader performance and subjective workflow experience when reporting bone age studies with a digital bone age reference as compared to the Greulich and Pyle atlas (G&P). We hypothesized that pediatric radiologists would achieve equivalent results with each method while digital workflow would improve speed, experience, and reporting quality.
Failure to predict response to immunotherapy (IO) limited its benefit in the treatment of head and neck squamous cell cancer (HNSCC) to 20% of patients or less. Biomarkers including tumor mutational burden (TMB) and programmed death ligand-1 (PD-L1) were evaluated as predictors of response to IO, but the results are inconsistent and with a lack of standardization of their methods. In this retrospective study, TMB and PD-L1 were measured by commercially available methodologies and were correlated to demographics, outcome, and response to PD-1 inhibitors. No correlation was found between TMB and PD-L1 levels. High TMB was associated with smoking and laryngeal primaries. PD-L1 was significantly higher in African Americans, patients with earlier stage tumors, nonsmokers, and nonethanol drinkers. Patients with high TMB fared better in univariate and multivariate survival analysis. No correlation was found between PD-L1 expression and prognosis. There was a statistically significant association between PFS and response to IO and TMB. There was no association between response to ICI and PD-L1 in this study, possibly affected by variations in the reporting method. Further studies are needed to characterize the biomarkers for IO in HNSCC, and this study supports further research into the advancement of TMB in prospective studies.